🔎 Trials Near Me

Akèy › Kolit

Etid klinik pou Kolit ap rekrite nan Etazini

12 etid pou Kolit ap rekrite patisipan nan sit atravè Etazini.

Vil ki gen plis etid

Pa eta

Etid ki fèk mete ajou

Tèks ofisyèl etid la (Anglè)

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 30, 2026 · NCT06598943

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT07012395

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT07845487

A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis

Ap rekriteFaz 2
Laj 2 a 11 · Tout sèks · Mizajou Aug 24, 2026 · NCT07470879

Autologous Stem Cell Transplant for Crohn's Disease

Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT03219359

Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer

Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jul 15, 2026 · NCT03819296

R-3750 in Patients With Mild to Moderate Ulcerative Colitis

Ap rekriteFaz 1
Laj 18 a 65 · Tout sèks · Mizajou Jun 12, 2026 · NCT05666960

Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies

Ap rekriteFaz 2
Laj 18 a 85 · Tout sèks · Mizajou May 22, 2026 · NCT07427017

Early Vedolizumab as First-Line for Immune-Related Colitis Therapy Trial

Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Nov 4, 2025 · NCT06841705

Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.